Abstract It is well known that obesity is frequently associated with low levels of serum high-density lipoprotein (HDL) cholesterol. However, the mechanism for this reduction has not been fully clarified. Cholesteryl ester transfer protein (CETP) transfers cholesteryl ester from HDL to apolipoprotein B-containing lipoproteins and plays an important role in regulating the concentration and composition of HDL. To elucidate the mechanism for the reduction of serum HDL cholesterol in obesity, we analyzed serum lipoproteins, CETP, and postheparin lipoprotein lipase (LPL) and hepatic triglyceride lipase (HTGL) activities in 30 obese subjects (17 women and 13 men, age 44±14 years, mean±SD). We also investigated the relationship between these variables, total adiposity, and indices of body fat distribution. The average body mass index of the obese subjects was 33.1±4.8 kg/m 2 (range, 26.4 to 43.8 kg/m 2 ). The obese subjects showed significantly lower serum HDL cholesterol levels than control subjects (1.04±0.28 versus 1.50±0.34 mmol/L, P<.01). In the obese subjects, both activities and protein mass of CETP and postheparin HTGL activities were significantly increased, whereas postheparin I t is well known that obese patients are often associated with low serum high-density lipoprotein (HDL) cholesterol levels. 1 Although some studies suggest that low HDL cholesterol in obesity might be a risk factor for coronary heart disease (CHD), 2 -3 few data show that low HDL cholesterol in obesity directly caused or was closely associated with the occurrence and development of CHD. Recent studies have shown that the degree of body fat distribution was more important for the occurrence of complications, particularly CHD, than body fat accumulation.
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t is well known that obese patients are often associated with low serum high-density lipoprotein (HDL) cholesterol levels. 1 Although some studies suggest that low HDL cholesterol in obesity might be a risk factor for coronary heart disease (CHD), 2 -3 few data show that low HDL cholesterol in obesity directly caused or was closely associated with the occurrence and development of CHD. Recent studies have shown that the degree of body fat distribution was more important for the occurrence of complications, particularly CHD, than body fat accumulation. 4 - 8 Therefore, it appears necessary to clarify the mechanism and pathophysiological significance of low serum HDL cholesterol levels in obesity.
Cholesteryl ester transfer protein (CETP) is a plasma glycoprotein that transfers cholesteryl ester (CE) from HDL to apolipoprotein (apo) B-containing lipopro-LPL activities were significantly decreased. CETP activities, independent of postheparin HTGL and LPL activities, were correlated negatively with HDL cholesterol (r=-.39, P<.05) and the cholesteryl ester to triglyceride ratio of HDL 2 and HDLj (r=-.36, P<.05; r=-M, P<.05, respectively). CETP activities were correlated positively with body mass index (r=.38, P<.05), body fat ratio (r=.42, P<.05), and subcutaneous fat area determined by abdominal CT scan imaging (r=.49, P<.05) and negatively with visceral fat/subcutaneous fat ratio (r=-.52, P<.01). After body weight reduction by caloric restriction, both activities and protein mass of CETP were reduced. These results suggest that high levels of plasma CETP may partly explain the reduction of serum HDL cholesterol in obese subjects and that plasma CETP levels may be regulated by the degree of total body fat accumulation. 9 and is one of the major determinants of plasma HDL cholesterol levels. 10 In Japan, some laboratories, including ours, reported that some types of familial hyperalphalipoproteinemia are associated with a genetic deficiency of plasma CETP. 1014 Our studies have shown that lipoprotein abnormalities in CETP-deficient patients are characterized by the presence of polydisperse low-density lipoprotein (LDL) 1112 and a marked elevation of HDL cholesterol. 13 ' 14 These results indicate that CETP plays an important role in modulating both the quality and quantity of plasma lipoproteins. Plasma CETP is synthesized by the liver, small intestine, spleen, adrenal gland, and adipose tissues. In particular, Jiang et al 15 reported that adipose tissue is one of the major sites of CETP synthesis in mammals.
Lipoprotein lipase (LPL) and hepatic triglyceride lipase (HTGL) are known to regulate HDL cholesterol levels. 1617 We reported that postheparin plasma LPL activity was positively correlated with serum HDL cholesterol levels in hypercholesterolemic and normolipidemic subjects 18 and that postheparin plasma HTGL activities were negatively correlated with the HDL 2 cholesterol/HDLj cholesterol ratio. 18 We also reported that hyperalphalipoproteinemic subjects with CHD and corneal opacity had a reduced activity of HTGL in postheparin plasma. 19 Although there are a number of reports on the correlation between serum HDL cholesterol level and body weight, there have been no reports regarding the relationship between CETP and the metabolism of serum lipoproteins in obese subjects. In the present study, we analyzed the serum lipoproteins and measured both activities and protein mass of CETP in obese subjects as well as postheparin LPL and HTGL activities so as to clarify the mechanism for low serum HDL cholesterol levels associated with obesity. Furthermore, we also investigated the relationship between these factors and body fat distribution, which has recently been clarified to be more important for the occurrence of complications of obesity.
Methods Subjects
A consecutive series of 30 obese subjects (17 premenopausal women and 13 men), 44±14 years old (mean±SD), was investigated in the present study. Their body weight was 87± 14 kg, and body mass index (BMI; body weight in kilograms divided by the square of height in meters) was 33.1±4.8 kg/m 2 . Ideal body weight was calculated by a formula reported previously. 20 None of the subjects received any therapy for weight reduction or any drugs known to affect lipid metabolism. Subjects with thyroid dysfunction, heavy alcohol consumption, cholestasis, familial hypercholesterolemia, or nephrotic syndrome were excluded from this study. Four women were hospitalized for further investigation of the effects of caloric restriction on serum lipoproteins. They received 2 months of diet therapy (20 kcal/kg of ideal body weight per day) in which 60% of the total calories was carbohydrate, 20% fat, and 20% protein. Twenty-six subjects with normal weight (15 premenopausal women and 11 men, 19.0<BMI<26.3 kg/m 2 ), 38±9 years old, served as control subjects.
Venous blood was drawn after an overnight fast. In all female subjects, the measurement was performed while they were in a follicular phase of their menstrual cycle. In 25 obese subjects from whom informed consent was obtained, body fat and Apo, apolipoprotein. Values are mean±SD.
distribution was assessed by a whole-body computed tomography (CT) scanning method.
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Isolation and Analysis of Lipoproteins
Very-low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), LDL, HDL 2 , and HDL, were isolated by sequential preparative ultracentrifugation at densities 1.006, 1.019, 1.063, 1.125, and 1.210 g/mL, respectively. 22 Total cholesterol (TC), free cholesterol, triglyceride (TG), and phosphohpid concentrations in serum and lipoprotein fractions were measured enzymatically with commercial kits (Determiner TC5, FC-555, TGS-555, and PL, Kyowa Medex). The concentrations of CE were calculated as (total cholesterol minus free cholesterol) times 1.68. HDL cholesterol was measured by a heparin-Ca 2+ precipitation method. 23 Serum concentrations of apo A-I, A-II, B, C-II, C-III, and E were measured by a single radial immunodiffusion method. 24 Protein concentration was determined by the method of Lowry et al. 25 
Activities and Protein Mass of CETP
Plasma CETP activity was measured according to the method of Albers et al. 26 Briefly, the transfer of u C-labeled HDL3 cholesteryl ester to the d< 1.060 g/mL lipoproteins was monitored after incubation for 18 hours at 37°C with or without the addition of 10 jiL plasma as a source of CETP. The HDL3 and the d< 1.060 g/mL lipoproteins were separated by heparin-MnCl 2 precipitation, and the radioactivity in the supernatant (HDL,) was then determined. The CETP activities were linearly increased within 18 hours of incubation.
CETP mass was measured according to the method of Sato et al (personal communication). This method was enzymelinked immunosorbent assay using monoclonal antibodies for CETP.
Measurement of Postheparin LPL and HTGL Activities
Postheparin plasma samples were obtained 15 minutes after the intravenous injection of heparin (50 IU/kg of body weight). The activities of LPL and HTGL were measured nonradioisotopicalh/ by a method described previously. 27 Briefly, a selective assay of each lipase was performed by adding sodium dodecyl sulfate (SDS) and NaCl to inactivate HTGL and LPL, respectively, basically according to the procedure of Baginsky and Brown. 28 Triolein emulsion with gum arabic was used as substrate. For LPL assay, 100 fiL of postheparin plasma was preincubated with 100 /iL of 100 mmol/L SDS for 60 minutes at 26°C. The reaction was then started by adding 10 ixL of SDS-treated postheparin plasma to 0.49 mL of the incubation mixture (0.1 mol/L NaCl, 0.2 mol/L Tris-HCl, pH 8.2, 5% bovine serum albumin, 15 mmol/L triolein, 100 to 140 /J.L of serum activator). After 60 minutes of incubation at 28°C, free fatty acids released were extracted by a modification of the method of Dole and Meinertz. 29 Then, each aliquot of the extract was evaporated under a nitrogen stream. After the residue was emulsified with Triton X-100, the NEFA kit (Nippon Shoji) reagent was added. After color formation, the turbidity was removed by addition of chloroform and centrifugation at 5500g for 30 minutes, and the absorbance at 550 nm was measured. For HTGL assay, the reaction was initiated by adding 5 /xL of postheparin plasma to 0.495 mL of the incubation mixture (0.75 mol/L NaCl, 0.2 mol/L Tris-HCl, 5% bovine serum albumin, 15 mmol/L triolein, pH 8.8). The subsequent procedure was the same as that for LPL assay.
Measurement of Body Fat Distribution
Body fat volume, body fat ratio (%), and the ratio of visceral fat to subcutaneous fat (V/S ratio) were determined by the CT scanning method as reported previously.
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- 21 CT scanning at seven levels was performed at the midpoints of forearms, head, and upper arms; at the level of the fourth intercostal space; at the level of the umbilicus; and at the midpoints of thighs and calves. The volume of each cylindrical segment was calculated by multiplying a cross-sectional area of fat tissue by height of each part. The volume of fat tissue of the whole body was calculated by summing fat tissue volume of 11 parts. Subcutaneous fat area (SFA) and intra-abdominal visceral fat area (VFA) were measured at the level of the umbilicus. Whole-body CT scans were made with the subject in a supine position by use of a General Electric CT/T scanner in 25 obese subjects.
Statistical Analysis
All values were expressed as mean±SD. The significance of differences in the means of serum lipids and lipoproteins between obese and control subjects was determined by Student's unpaired t test. Simple correlation coefficients were calculated with Pearson's method. Partial correlation coefficients were also calculated for the parameters with significant simple correlation coefficients. For comparison of CETP activity before and after weight reduction, Student's paired t test was used.
Results
Clinical profiles and serum concentrations of lipids and apolipoproteins in the obese and control subjects are shown in Table 1 . The HDL cholesterol levels were significantly decreased in obese subjects compared with those of control subjects. This difference was apparent in both male and female subjects. There was no significant difference in serum concentrations of TC between obese and control subjects. Furthermore, serum TG levels in obese subjects were also significantly higher than those in nonobese control subjects. Serum levels of apo A-I tended to be decreased in obese subjects and were significantly decreased in female obese subjects. Serum apo B levels were significantly increased in obese subjects. Table 2 shows the concentrations of TC and TG and the ratio of CE to TG (CE/TG) in each lipoprotein fraction separated by preparative ultracentrifugation. Concentrations of VLDL cholesterol and TG in obese subjects were significantly higher than those in control subjects, while HDL 2 cholesterol levels were significantly lower. IDL TG levels were significantly increased in obese subjects over those in control subjects, while HDL 2 TG and the CE/TG ratio of HDL, were significantly decreased in obese subjects. The low serum HDL cholesterol levels in obesity shown in Table 1 were due to the decrease in HDL 2 cholesterol. These results were consistent with previous reports showing the increase in VLDL and decrease in HDL in obese subjects.
To clarify the mechanism for the reduction of HDL in obese subjects, activities of protein or enzymes involved in HDL metabolism were determined. Fig 1 shows the CETP activities and the postheparin plasma activities of LPL and HTGL. HTGL activities were significantly higher in male obese subjects than in control subjects (P<.05) (Fig 1C) , while LPL activities were significantly reduced in female obese subjects (P<.Q5) (Fig IB) . Plasma CETP activities of obese subjects were significantly increased in obese subjects of both sexes compared with control subjects (27.7±3.7 versus 22.0±2.8% per 10 nL per 18 hours, P<.001, Fig 1A) . The protein mass of CETP was also elevated in parallel with the activities (2.73+0.61 versus 2.14±0.63 /xg/mL, P<.001).
There was a close correlation between CETP activities and protein mass in all subjects, including both obese and control subjects (r=.8O, P<.001). Such a correlation was demonstrated in obese subjects Q>=0.149vc-1.33, r=.85,P<.001) and in control subjects Q>=0.151JC-1.16, r=.73,P<.001). Table 3 shows the simple correlation coefficients between lipoproteins, CETP activities, and postheparin LPL and HTGL activities in all obese subjects. CETP activities were correlated negatively with HDL choles- and VLDL TG levels in obese subjects were significantly higher than those in control subjects, CETP activities and mass in obese subjects were not significantly correlated with those two variables. We undertook a partial correlation analysis by holding postheparin LPL and HTGL activities constant to ascertain whether the reduction of HDL cholesterol was correlated, independent of LPL and HTGL, with plasma CETP activities in obese subjects. Table 4 shows the partial correlation coefficients of HDL cholesterol and the CE/TG ratio of HDL 2 and HDL, to CETP activities. CETP activities were, independent of postheparin LPL and HTGL activities, negatively correlated with HDL cholesterol and the CE/TG ratio of HDL 2 and HDL3. Table 5 shows the correlations of CETP, HTGL, and LPL activities to total adiposity and indices of body fat distribution. Both the activities of LPL and of HTGL were not significantly correlated with these variables. In contrast, CETP activities were significantly correlated with body fat mass and body fat ratio (r=.5O, P<.Q1 and r=.42, P<.05, respectively). The results were also illustrated in (Fig 2C and 2D) .
Finally, we investigated the effect of body weight reduction on plasma CETP levels in four obese subjects. After 2 months of diet therapy, the average body weight decreased from 84±14 to 78±11 kg, while average BMI was reduced from 33.9+3.7 to 31.7±3.0 kg/m 2 . Serum TG levels significantly decreased, and HDL cholesterol levels tended to increase. As shown in Fig 3, both activities (P<.05) and protein mass (P<.05) of CETP were significantly decreased after the diet therapy. Specific activities of CETP (CETP activity divided by CETP mass ratio) were not significantly changed. 
Discussion
The present study, for the first time, demonstrated the changes in plasma CETP activities as well as protein mass in obesity and clarified their relation to serum lipoproteins and body fat accumulation. In obese subjects, serum HDL cholesterol levels were significantly lower than those in control subjects, which was consistent with previous reports. 1 -3 Both activities and protein mass of CETP were elevated in obese subjects, and these changes in CETP returned toward a normal range after body weight reduction. A precise analysis of body composition by CT scanning that we developed revealed that plasma CETP mass and activity were positively correlated to total body fat mass and that those were correlated positively with SFA and negatively with V/S ratio. Serum HDL cholesterol levels were negatively correlated with CETP activities. These results suggest that the change in CETP may contribute to the reduction of HDL cholesterol in obese subjects and that plasma CETP levels may be increased in parallel with the degree of total body fat accumulation as well as regional fat distribution. The mechanism for the elevation of plasma CETP in obese subjects and its pathophysiological significance remain to be investigated. Recently it has been reported that CETP is synthesized by adipose tissues as well as the liver and small intestines 15 and that an alternative splicing of the CETP mRNA occurs in adipose tissues. 30 Therefore, we speculate that the increased activity of plasma CETP may be caused by the accumulation of fat tissues, which synthesize more CETP mass than other organs. This may be supported by the good correlation observed between CETP activity and mass in obese subjects. Subcutaneous fat may play a crucial role in regulating plasma CETP levels.
The mechanism for the decrease of serum HDL cholesterol in obesity has not been fully elucidated. Previous studies showed that LPL and HTGL might play a role in determining serum HDL cholesterol levels in obese subjects.
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' 32 The present study clearly demonstrated that CETP was significantly correlated with serum HDL cholesterol levels in obesity, independent of HTGL and LPL activities, by partial correlation analysis. Although the cause-and-effect relationship could not be proved, we think that this protein may play an important role in determining serum HDL cholesterol level in obese subjects.
Some laboratories, including ours, have shown that visceral fat accumulation was closely correlated with metabolic and cardiovascular complications, 5 ' 33 suggesting that visceral fat accumulation may be chiefly involved in the atherogenesis of obesity. 3435 The present study shows that plasma CETP levels were positively correlated with total body fat and SFA and negatively with V/S ratio. However, there was no significant correlation between plasma CETP levels and VFA. These results indicate that the accumulation of subcutaneous fat tissues in obesity contributes to the increase of plasma CETP levels, although serum HDL cholesterol levels were reported to be decreased in visceral fat obesity (VFO), similar to subcutaneous fat obesity. 4 Therefore, we speculate that factors other than CETP might be involved in the mechanism for the reduced HDL cholesterol levels in VFO. Furthermore, it may be possible that subcutaneous fat tissues might express more CETP than visceral fat tissues, since plasma CETP levels were positively correlated with SFA but not with VFA.
Reverse cholesterol transport has been thought to be one of the major protective systems against atherosclerosis. 3637 CETP is considered to play an important role in this system. In the first step of this system, HDL removes cholesterol from peripheral tissue, followed by its esterification by lecithin-cholesterol acyltransferase (LCAT). CETP transfers the removed CE from HDL to apo B-containing lipoproteins, and the transferred CE is finally taken up by the liver, which is a terminal of reverse cholesterol transport. It has been demonstrated that plasma CETP is regulated by some genetic and environmental factors. High plasma CETP activities were demonstrated in patients with hypercholesterolemia, 38 primary biliary cirrhosis, 39 nephrotic syndrome, 40 and in patients taking probucol. 41 Plasma CETP level revealed an increase in subjects with hypercholesterolemia or combined hyperlipidemia but not in subjects with moderate hypertriglyceridemia. 38 In the present study, serum TG levels in obese subjects increased moderately, and CETP activities and mass in obese subjects were not significantly correlated with those two variables (Table 3) . Conversely, low plasma CETP activity was demonstrated in patients with hypothyroidism 42 and in heavy alcohol drinkers. 4344 The present study demonstrated that plasma CETP levels inceased in obesity.
What is the pathophysiological significance of reduced HDL cholesterol levels in obese subjects? Since numerous epidemiological studies showed that serum HDL cholesterol levels were negatively correlated with the incidence of CHD, 45 ' 46 it has been generally accepted that the increase in serum HDL cholesterol is more desirable, whereas its decrease is more dangerous. However, we reported some interesting and exceptional observations against this concept. We reported two hyperalphalipoproteinemic subjects with low HTGL activities that were accompanied by corneal opacity and CHD. 19 We also reported hyperalphalipoproteinemic heavy alcohol drinkers with low plasma CETP activity, 43 ' 44 some of whom suffered from CHD. Conversely, we reported that the decrease in HDL cholesterol was closely correlated with the reduction in Achilles tendon thickness in patients with familial hypercholesterolemia during treatment with probucol, 47 which was shown to raise plasma CETP activity. 41 Furthermore, we recently found that large CE-rich HDL particles obtained from patients with homozygous CETP deficiency could not prevent macrophages from accumulating CE induced by acetylated LDL. 48 Therefore, these observations indicate that it is essential to examine the cell-biological properties of HDL, as well as to measure serum HDL cholesterol levels, for the purpose of clarifying an antiatherogenic role of HDL.
On the other hand, human adipocytes were reported to specifically bind HDL. 49 - 50 Some investigators showed that CETP functions to transfer lipids between lipoproteins and some cells, 51 -52 such as macrophages, fibroblasts, smooth muscle cells, and hepatocytes, as well as among plasma lipoproteins. From these observations, adipocytes may play a unique role in the metabolism of lipoproteins, especially HDL. Further studies are in progress to investigate the interaction between plasma CETP and adipocytes and to further clarify the physiological significance of CETP synthesized by adipose tissues.
